Moderna just announced that they are expanding to four countries in Asia Pacific – Malaysia, Singapore, Taiwan and Hong Kong!
Moderna Expands To Malaysia, Singapore, Taiwan + HK!
On 15 February 2022, Moderna announced that it is expanding its commercial network across Asia by creating new subsidiaries in Malaysia, Singapore, Taiwan and Hong Kong.
These new subsidiaries are meant to support the delivery of mRNA vaccines and therapeutics, and may not involve research and development, or manufacturing.
In May 2021, Moderna announced a collaboration with the South Korean government to explore research and manufacturing in South Korea.
At the end of December 2021, Moderna announced that it would build an mRNA vaccine manufacturing facility in Victoria, Australia.
“2021 was a year of impact for Moderna, and I am proud to see continued growth in 2022 as we expand our presence in Asia. After a decade of pioneering the development of our mRNA platform, we were ready to play a critical role in combating the COVID-19 pandemic globally,” said Stéphane Bancel, Chief Executive Officer of Moderna.
“With the addition of four subsidiaries in Asia, we look forward to new opportunities to leverage our mRNA platform to help solve health challenges, including those with a high burden of disease in the Asia-Pacific region.”
Moderna CEO Stephane Bancel was recently the subject of speculation and misinformation, after closing his Twitter account. You can read all about it here.
- Did Doctors In China Kill COVID-19 Using Warm / Salt Water?
- Did Moderna CEO Dump Stock + Close Twitter Account?!
- Does February 2022 Happen Only Every 823 Years?!
- Real COVID-19 Home Treatment Advice By Dr. Noor Hisham?!
- How To Walk-In For Free Sinovac Booster At Offsite PPV!
If you like our work, please support us by visiting our sponsors, or donating to our fund. Thank you!